Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media
- PMID: 10979911
- DOI: 10.1086/315822
Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media
Abstract
Pneumococcal surface protein A (PspA), pneumococcal surface adhesin A (PsaA), and pneumolysin (Ply) are common to virtually all Streptococcus pneumoniae isolates. They are immunogenic and protective against pneumococcal challenge in animals and are the major candidates for a protein-based pneumococcal vaccine for humans. However, little is known of the natural development of antibodies to these proteins in humans. The objective of this study was to evaluate the natural development of antibodies to PspA, PsaA, and Ply in relation to pneumococcal infection and carriage in young children. Serum antibodies to these proteins were measured by EIA in children at ages 6, 12, 18, and 24 months and in their mothers. All age groups were capable of producing antibodies to the 3 proteins. The antibody concentrations increased with age and were strongly associated with pneumococcal exposure, whether by carriage or infection (acute otitis media).
Similar articles
-
Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal surface adhesin a, pneumolysin, and pneumococcal surface protein a in children.J Infect Dis. 2001 Mar 15;183(6):887-96. doi: 10.1086/319246. Epub 2001 Feb 21. J Infect Dis. 2001. PMID: 11237805
-
Development of natural antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A and pneumolysin in Filipino pregnant women and their infants in relation to pneumococcal carriage.Vaccine. 2006 Jan 9;24(1):57-65. doi: 10.1016/j.vaccine.2005.07.055. Epub 2005 Aug 3. Vaccine. 2006. PMID: 16115703
-
Antibody response to the pneumococcal proteins pneumococcal surface adhesin A and pneumolysin in children with acute otitis media.Pediatr Infect Dis J. 2001 May;20(5):482-7. doi: 10.1097/00006454-200105000-00003. Pediatr Infect Dis J. 2001. PMID: 11368104
-
The potential for using protein vaccines to protect against otitis media caused by Streptococcus pneumoniae.Vaccine. 2000 Dec 8;19 Suppl 1:S87-95. doi: 10.1016/s0264-410x(00)00285-1. Vaccine. 2000. PMID: 11163470 Review.
-
Pneumococcal vaccines: an update on current strategies.Vaccine. 2004 Jun 2;22(17-18):2209-20. doi: 10.1016/j.vaccine.2003.11.038. Vaccine. 2004. PMID: 15149779 Review.
Cited by
-
Subclass distribution of natural salivary IgA antibodies against pneumococcal capsular polysaccharide of type 14 and pneumococcal surface adhesin A (PsaA) in children.Clin Exp Immunol. 2006 Mar;143(3):543-9. doi: 10.1111/j.1365-2249.2006.03009.x. Clin Exp Immunol. 2006. PMID: 16487254 Free PMC article.
-
Mucosal immunology of vaccines against pathogenic nasopharyngeal bacteria.J Clin Pathol. 2004 Oct;57(10):1015-21. doi: 10.1136/jcp.2004.016253. J Clin Pathol. 2004. PMID: 15452151 Free PMC article. Review.
-
Intranasal Vaccination With Lipoproteins Confers Protection Against Pneumococcal Colonisation.Front Immunol. 2018 Oct 18;9:2405. doi: 10.3389/fimmu.2018.02405. eCollection 2018. Front Immunol. 2018. PMID: 30405609 Free PMC article.
-
Development of a multiplexed bead-based immunoassay for the simultaneous detection of antibodies to 17 pneumococcal proteins.Eur J Clin Microbiol Infect Dis. 2011 Apr;30(4):521-6. doi: 10.1007/s10096-010-1113-x. Epub 2010 Nov 18. Eur J Clin Microbiol Infect Dis. 2011. PMID: 21086008 Free PMC article.
-
Effect of recurrent invasive pneumococcal disease on serum anti-pneumolysin IgG titres in HIV infected adults.Vaccine. 2009 Jun 12;27(29):3881-4. doi: 10.1016/j.vaccine.2009.04.026. Epub 2009 May 3. Vaccine. 2009. PMID: 19376181 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical